Pilot visits for GIRFT pancreatic cancer review about to begin

Pilot visits for GIRFT’s national review of pancreatic cancer services are about to get under way, ahead of national deep dives at all specialist centres and their referring hospitals in England.

Data-driven meetings with the surgical centre at Oxford University Hospitals and its referring trusts (Great Western Hospitals, Buckinghamshire Healthcare, Milton Keynes University Hospital and Royal Berkshire) are planned for 23rd January 2024.

A second pilot meeting with the surgical centre at University Hospitals Coventry and Warwickshire and its referring trusts (South Warwickshire University and George Eliot Hospital) takes place on 26th January.

Once the pilots are evaluated, national deep dives are expected to begin in early March.

In August 2023, GIRFT appointed a team of five specialist clinicians to lead the national review into services for pancreatic cancer patients in England. The workstream is designed to support the delivery of the Optimal Care Pathway, a Pancreatic Cancer UK-led initiative which has brought together 300 health professionals and people affected to agree on how standards of diagnosis, treatment and care of those with pancreatic cancer and their families can be improved.

GIRFT’s national review of services will involve data-driven deep dives at all specialist centres and their referring hospitals in England, identifying their progress against the recommendations in the Optimal Care Pathway. It will highlight actions the NHS providers need to take to improve services, as well as gathering examples of good practice to share with other NHS teams and the NHS England Cancer Programme.

A resulting national report will outline the extent of variation across England and provide recommendations to improve processes and approaches to achieve better ways of working to improve outcomes.

More updates